Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to -$2.9 million.

  • CollPlant Biotechnologies' Net Cash Flow rose 1978.82% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.0 million, marking a year-over-year increase of 2750.04%. This contributed to the annual value of -$14.6 million for FY2024, which is 42020.63% down from last year.
  • Per CollPlant Biotechnologies' latest filing, its Net Cash Flow stood at -$2.9 million for Q3 2025, which was up 1978.82% from -$2.4 million recorded in Q2 2025.
  • Over the past 5 years, CollPlant Biotechnologies' Net Cash Flow peaked at $28.1 million during Q1 2022, and registered a low of -$33.8 million during Q4 2021.
  • Over the past 5 years, CollPlant Biotechnologies' median Net Cash Flow value was -$2.9 million (recorded in 2025), while the average stood at -$1.5 million.
  • Examining YoY changes over the last 5 years, CollPlant Biotechnologies' Net Cash Flow showed a top increase of 79461.66% in 2021 and a maximum decrease of 57994.37% in 2021.
  • Over the past 5 years, CollPlant Biotechnologies' Net Cash Flow (Quarter) stood at -$33.8 million in 2021, then surged by 59.8% to -$13.6 million in 2022, then skyrocketed by 80.02% to -$2.7 million in 2023, then fell by 29.63% to -$3.5 million in 2024, then increased by 18.29% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q3 2025, -$2.4 million for Q2 2025, and -$1.2 million during Q1 2025.